Health CanadaGeneral Alert
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary B...
Published: December 5, 2022Recall ID: 72307Category: generalCountry: Canada
Reason for Recall / Hazard
New safety information
Product Description & Identification
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
Affected Products
OCALIVA (obeticholic acid)
Additional Source Details
| Field | Value |
|---|---|
| N I D | 72307 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/ocaliva-obeticholic-acid-new-contraindication-treatment-primary-biliary-cholangitis |
| Issue | New safety information |
| Title | OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC) |
| Product | OCALIVA (obeticholic acid) |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2022-12-05 |
| Organization | Marketed health products |